ClinicalTrialsFinder

Philadelphia-Negative ALL Clinical Trials in Suzhou, Jiangsu

1 recruitingSuzhou, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.

Philadelphia-Negative ALLALL, Adult
Chen Suning124 enrolled1 locationNCT06250959